Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.92 USD | -2.58% | +7.76% | +74.07% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 505M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -144M | EV / Sales 2024 * | - |
Net cash position 2024 * | 182M | Net cash position 2025 * | 57.6M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.43
x | P/E ratio 2025 * |
-3.78
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Larimar Therapeutics, Inc.
1 day | -2.58% | ||
1 week | +7.76% | ||
Current month | +14.95% | ||
1 month | +9.70% | ||
3 months | +26.11% | ||
6 months | +183.87% | ||
Current year | +74.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 20-05-27 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 20-05-27 |
Frank Thomas
BRD | Director/Board Member | 54 | 20-05-27 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 23-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 0 M€ | +3.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 7.92 | -2.58% | 210,647 |
24-05-07 | 8.13 | -1.33% | 168,502 |
24-05-06 | 8.24 | +6.12% | 339,453 |
24-05-03 | 7.765 | +2.04% | 231,966 |
24-05-02 | 7.61 | +3.54% | 220,416 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+74.07% | 505M | |
+2.93% | 108B | |
+8.82% | 105B | |
+0.82% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B |
- Stock Market
- Equities
- LRMR Stock